Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
40.38
+1.67 (4.31%)
At close: Nov 4, 2025, 4:00 PM EST
39.27
-1.11 (-2.75%)
After-hours: Nov 4, 2025, 6:50 PM EST
Bruker Revenue
Bruker had revenue of $860.50M in the quarter ending September 30, 2025, a decrease of -0.45%. This brings the company's revenue in the last twelve months to $3.44B, up 6.10% year-over-year. In the year 2024, Bruker had annual revenue of $3.37B with 13.56% growth.
Revenue (ttm)
$3.44B
Revenue Growth
+6.10%
P/S Ratio
1.78
Revenue / Employee
$301,764
Employees
11,396
Market Cap
6.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.37B | 401.90M | 13.56% |
| Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
| Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
| Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
| Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
BRKR News
- 10 hours ago - Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend - Business Wire
- 1 day ago - Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Bruker Reports Third Quarter 2025 Financial Results - Business Wire
- 13 days ago - Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast - Business Wire
- 4 weeks ago - Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University - Business Wire
- 4 weeks ago - New Preferred Stock And Baby Bond IPOs, September 2025 - Seeking Alpha
- 2 months ago - BRUKP: Bruker Corp 6.375% Mandatory Convertible Preferred Stock IPO - Seeking Alpha
- 2 months ago - Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock - Business Wire